MAY 20, 2021 8:00 AM PDT

Ovarian Cancer Screening More Beneficial for Early Cancer Detection

WRITTEN BY: Tara Fernandez

A UK-based research study has shown that while ovarian cancer screening is beneficial for detecting cancers earlier, it did not result in a reduction of deaths from the disease.

The study from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) was published in The Lancet. Here, researchers tracked over 200,000 women between the ages of 50 and 74 over a 16 year period. Some underwent no routine screening, others did an annual ultrasound scan and a third group did a more comprehensive screening test involving both a blood test and an ultrasound test.

"UKCTOCS is the first trial to show that screening can definitely detect ovarian cancer earlier, said Usha Menon, the UKTOCS lead investigator. “However, this very large, rigorous trial shows clearly that screening using either of the approaches we tested did not save lives. We, therefore, cannot recommend ovarian cancer screening for the general population using these methods.”

Ovarian cancer is the fifth most common cause of cancer deaths in women; an estimated 13.770 women in the U.S. will die of ovarian cancer in 2021. 

The results of the trial highlighted how screening was not effective in women who did not display any ovarian cancer symptoms, but the researchers say, an early diagnosis may improve outcomes in those experiencing symptoms. Here, detecting cancer earlier could help reduce the amount and intensity of treatment required.

Unfortunately, the results of the trial show that such screening programs miss the mark in terms of saving lives. However, the research team said that the study did generate valuable insights into design strategies for future clinical trials.

 

 

Sources: University College London, The Lancet.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 03, 2021
Drug Discovery & Development
A pediatric-friendly drug to combat snail fever
AUG 03, 2021
A pediatric-friendly drug to combat snail fever
           Schistosomiasis, also known as Bilharzia or snail fever, is a disease  ...
AUG 05, 2021
Clinical & Molecular DX
Wearable Patch Senses Blood Vessel Blockages
AUG 05, 2021
Wearable Patch Senses Blood Vessel Blockages
The cardiovascular system is like a network of highways, filled with an estimated 25 trillion red blood cells that conti ...
SEP 08, 2021
Microbiology
Authorities Work to Contain Nipah Virus Outbreak in India
SEP 08, 2021
Authorities Work to Contain Nipah Virus Outbreak in India
Nipah virus is one of the world's deadliest viruses. It has caused several small outbreaks in Southeast Asia since it em ...
SEP 30, 2021
Clinical & Molecular DX
How Babies Look at Objects Linked to Future Autism Diagnoses
SEP 30, 2021
How Babies Look at Objects Linked to Future Autism Diagnoses
At nine months old, most babies have started moving around independently and are curiously exploring the exciting new wo ...
OCT 17, 2021
Technology
How Do People Feel About Facial Recognition Tools In Healthcare?
OCT 17, 2021
How Do People Feel About Facial Recognition Tools In Healthcare?
Facial image data and recognition tools have become a nearly ubiquitous part of our society: we use it to unlock smartph ...
OCT 27, 2021
Drug Discovery & Development
A novel drug delivery device to treat macular degeneration.
OCT 27, 2021
A novel drug delivery device to treat macular degeneration.
Last Friday, October 22nd, the United States Food and Drug Administration (FDA) approved a first of its kind d ...
Loading Comments...